Genetic and epigenetic alterations of netrin-1 receptors in gastric cancer with chromosomal instability

被引:11
|
作者
Toda, Keisuke [1 ]
Nagasaka, Takeshi [1 ]
Umeda, Yuzo [1 ]
Tanaka, Takehiro [2 ]
Kawai, Takashi [1 ]
Fuji, Tomokazu [1 ]
Taniguchi, Fumitaka [1 ]
Yasui, Kazuya [1 ]
Kubota, Nobuhito [1 ]
Takehara, Yuko [1 ]
Tazawa, Hiroshi [1 ]
Kagawa, Shunsuke [1 ]
Sun, Dong-Sheng [1 ,3 ]
Nishida, Naoshi [4 ]
Goel, Ajay [5 ,6 ]
Fujiwara, Toshiyoshi [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama, Okayama 7008558, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama, Okayama 7008558, Japan
[3] Kailuan Gen Hosp Tangshan Hebei Prov, Dept Oncol, Tangshan 063000, Hebei, Peoples R China
[4] Kinki Univ, Fac Med, Dept Gastroenterol & Hepatol, Osaka 5898511, Japan
[5] Baylor Univ, Med Ctr, Ctr Gastrointestinal Canc Res, Ctr Epigenet,Canc Prevent & Canc Gen,Baylor Res I, Dallas, TX 75246 USA
[6] Baylor Univ, Charles A Sammons Canc Ctr, Dallas, TX 75246 USA
关键词
Gastric cancer; Methylation; Chromosomal instability; DCC; UNC5C; Netrin-1; receptors; HELICOBACTER-PYLORI INFECTION; DIFFERENTIATED ADENOCARCINOMA; MICROSATELLITE INSTABILITY; TUMOR PROGRESSION; COLON-CANCER; DCC; HETEROZYGOSITY; IDENTIFICATION; METHYLATION; MUTATIONS;
D O I
10.1186/s13148-015-0096-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The gene expressions of netrin-1 dependence receptors, DCC and UNC5C, are frequently downregulated in many cancers. We hypothesized that downregulation of DCC and UNC5C has an important growth regulatory function in gastric tumorigenesis. Results: In the present study, a series of genetic and epigenetic analyses for DCC and UNC5C were performed in a Japanese cohort of 98 sporadic gastric cancers and corresponding normal gastric mucosa specimens. Loss of heterozygosity (LOH) analyses and microsatellite instability (MSI) analysis was applied to determine chromosomal instability (CIN) and MSI phenotypes, respectively. More than 5 % methylation in the DCC and UNC5C promoters were found in 45 % (44/98) and 32 % (31/98) gastric cancers, respectively, and in 9 % (9/105) and 5 % (5/105) normal gastric mucosa, respectively. Overall, 70 % (58 of 83 informative cases) and 51 % (40 of 79 informative cases) of gastric cancers harbored either LOH or aberrant methylation in the DCC and UNC5C genes, respectively. In total, 77 % (51 of 66 informative cases) of gastric cancers showed cumulative defects in these two dependence receptors and were significantly associated with chromosomal instability. Both DCC and UNC5C were inactivated in 97 % of CIN-positive gastric cancers and in 55 % of CIN-negative gastric cancers. Conclusions: Defect in netrin receptors is a common feature in gastric cancers. DCC alterations are apparent in the early stages, and UNC5C alterations escalate with the progression of the disease, suggesting that the cumulative alterations of netrin-1 receptors was a late event in gastric cancer progression and emphasizing the importance of this growth regulatory pathway in gastric carcinogenesis.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Netrin-1/receptors regulate the pathogenesis in Parkinson's diseases
    Ahn, Eun Hee
    Kang, Seong Su
    Ye, Keqiang
    PRECISION AND FUTURE MEDICINE, 2021, 5 (02): : 50 - 61
  • [32] NETRIN-1 RECEPTORS CONTROL MESOCORTICAL DOPAMINE CONNECTIVITY IN ADOLESCENCE
    Flores, Cecillia
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S37 - S38
  • [33] Epigenetic alterations in gastric cancer
    Fu, Du-Guan
    MOLECULAR MEDICINE REPORTS, 2015, 12 (03) : 3223 - 3230
  • [34] Netrin-1 promotes cell neural invasion in gastric cancer via its receptor neogenin
    Yin, Kai
    Wang, Linjun
    Xia, Yiwen
    Dang, Shengchun
    Zhang, Xuan
    He, Zhongyuan
    Xu, Jianghao
    Shang, Mengyuan
    Xu, Zekuan
    JOURNAL OF CANCER, 2019, 10 (14): : 3197 - 3207
  • [35] Serum netrin-1 as a biomarker for colorectal cancer detection
    Li, Bo
    Shen, Kexin
    Zhang, Jiayu
    Jiang, Yang
    Yang, Ting
    Sun, Xiaoxu
    Ma, Xiaoming
    Zhu, Jinzhou
    CANCER BIOMARKERS, 2020, 28 (03) : 391 - 396
  • [36] Pharmacological targeting of netrin-1 inhibits EMT in cancer
    Lengrand, Justine
    Pastushenko, Ievgenia
    Vanuytven, Sebastiaan
    Song, Yura
    Venet, David
    Sarate, Rahul M.
    Bellina, Melanie
    Moers, Virginie
    Boinet, Alice
    Sifrim, Alejandro
    Rama, Nicolas
    Ducarouge, Benjamin
    Van Herck, Jens
    Dubois, Christine
    Scozzaro, Samuel
    Lemaire, Sophie
    Gieskes, Sarah
    Bonni, Sophie
    Collin, Amandine
    Braissand, Nicolas
    Allard, Justine
    Zindy, Egor
    Decaestecker, Christine
    Sotiriou, Christos
    Salmon, Isabelle
    Mehlen, Patrick
    Voet, Thierry
    Bernet, Agnes
    Blanpain, Cedric
    NATURE, 2023, 620 (7973) : 402 - +
  • [37] Serum netrin-1 as a biomarker for colorectal cancer detection
    Zhu, J.
    Xi, L.
    Wu, A.
    Ma, X.
    Zhang, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [38] Netrin-1 in cancer: Potential biomarker and therapeutic target?
    Kefeli, Umut
    Kefeli, Aysegul Ucuncu
    Cabuk, Devrim
    Isik, Ulas
    Sonkaya, Alper
    Acikgoz, Ozgur
    Ozden, Ercan
    Uygun, Kazim
    TUMOR BIOLOGY, 2017, 39 (04)
  • [39] Pharmacological targeting of netrin-1 inhibits EMT in cancer
    Justine Lengrand
    Ievgenia Pastushenko
    Sebastiaan Vanuytven
    Yura Song
    David Venet
    Rahul M. Sarate
    Melanie Bellina
    Virginie Moers
    Alice Boinet
    Alejandro Sifrim
    Nicolas Rama
    Benjamin Ducarouge
    Jens Van Herck
    Christine Dubois
    Samuel Scozzaro
    Sophie Lemaire
    Sarah Gieskes
    Sophie Bonni
    Amandine Collin
    Nicolas Braissand
    Justine Allard
    Egor Zindy
    Christine Decaestecker
    Christos Sotiriou
    Isabelle Salmon
    Patrick Mehlen
    Thierry Voet
    Agnès Bernet
    Cédric Blanpain
    Nature, 2023, 620 : 402 - 408
  • [40] Serum Netrin-1 as a biomarker for Endometrium Cancer detection
    Kose, Osman
    Kose, Elif
    Gok, Koray
    Bostanci, Mehmet S.
    Aslan, Mehmet M.
    Gozukara, Irmak Sezen
    Unal, Orhan
    REVISTA PERUANA DE GINECOLOGIA Y OBSTETRICIA, 2023, 69 (04):